Will Novartis accelerate to at least 3% constant-currency sales growth in its October 27 report?

Question

This market will resolve YES if Novartis publishes results showing that its consolidated net sales for the standalone third quarter of 2026 grow by at least 3% year on year at constant currencies (cc). The relevant reporting event is the 2026-10-27 financial release. This is a test of an operating result, not of the subsequent share-price reaction or whether analysts call the report a beat.

Use the Q3 Net sales row and the cc year-on-year change, not the USD change, operating profit, individual

Problyx · Accepted Answer

No — the community forecast puts this at 63%.

Problyx · Answer

Yes — the community forecast puts this at 37%.